Russia's largest fertility operator AVA-Peter Clinic has been acquired by one of the country's richest men. We talk to a well-placed contact about what this might mean for a market that has seen a dearth of M&A activity in recent years.
Speculation as to whether Russian investor Sistema could sell its clinic chain Medsi continues as its asset became profitable this year. But it can't sell immediately. Sistema faces paying almost €2bn in damages in an unrelated court case, and the court has "frozen" Medsi, which could be liquidated to pay off the debt. We speak to a well placed local contact to find out more.
Chinese insurance giant Ping An has become the second largest shareholder in Singapore-based Fullerton Health Corporation, after investing RMB800m ($121m) to acquire a 17% stake.
In an unusual move, Mediclinic has appointed its chief medical officer Dr Carel Aron (Ronnie) van der Merwe as CEO, replacing Danie Meintjes, who has held the post since 2010. Meanwhile we ask what Mediclinic's break up value would be? The group is currently valued at £3.95bn on the London Stock Exchange.
Some of Europe's most successful healthcare companies have gone public recently - but is an IPO a guarantee of success? We take a look at how some of those companies have fared in the last 6-18 months.
Financially troubled Indian hospital group SevenHills Healthcare could be put up for auction, after its lenders filed for insolvency against the group.
A source close to the private radiology group Amethyst in Romania denies the company is for sale, telling Healthcare Europa “these are vicious rumours spread by competitors".
Healthcare Business International users cookies to improve the functionality, performance, and effectiveness of our communications. Detailed information on the use of cookies is provided in our Cookies Policy. By continuing to use this site, or by clicking "I agree" you consent to the use of cookies.